Previous close | 196.75 |
Open | 195.95 |
Bid | 199.35 x 20000 |
Ask | 202.50 x 20000 |
Day's range | 195.95 - 197.90 |
52-week range | 126.40 - 218.20 |
Volume | |
Avg. volume | 25 |
Market cap | 29.643B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 32.66 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.79 (0.90%) |
Ex-dividend date | 08 May 2024 |
1y target est | N/A |
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
STERIS' (STE) fourth-quarter performance in AST is dented by a decline in capital equipment revenues. The contraction of margins is concerning.